Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keungmo Yang

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Liver Cancer|May 7, 2026
Low Tumor Burden Predicts Benefit from Transarterial Treatment in Hepatocellular Carcinoma with Extrahepatic Metastasis: A Nationwide Cohort StudyJaejun Lee, Hyun Yang, Keungmo Yang, et al.
Journal of Korean Medical Science|January 13, 2026
Case 21: A 29-Year-Old Man With Bloating and BorborygmusYoon Kang, Yongeun Cho, Ji Eun Baek, et al.
Translational Gastroenterology and Hepatology|November 11, 2025
The prognostic impact of statin exposure in metabolic dysfunction-associated steatotic liver disease: a cohort studyKeungmo Yang, Seung Yun Chae, Jaejun Lee, et al.
Clinical and Molecular Hepatology|March 10, 2017
Hepatogastric fistula as a rare complication of pyogenic liver abscessKyu Won Lee, Hee Yeon Kim, Chang Wook Kim, et al.
Nature Biomedical Engineering|October 31, 2023
A temperature-responsive intravenous needle that irreversibly softens on insertionKaren-Christian Agno, Keungmo Yang, Sang-Hyuk Byun, et al.
Anticancer Research|July 3, 2019
Reduction of Intrahepatic Tumour by Hepatic Arterial Infusion Chemotherapy Prolongs Survival in Hepatocellular CarcinomaPil Soo Sung, Keungmo Yang, Si Hyun Bae, et al.
Clinical Nutrition (Edinburgh, Scotland)|February 28, 2025
Glucosamine supplementation attenuates progression of metabolic dysfunction-associated steatotic liver disease and related comorbiditiesTom Ryu, Young Chang, Jeong-Ju Yoo, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|June 8, 2019
Pathologic complete response to chemoembolization improves survival outcomes after curative surgery for hepatocellular carcinoma: predictive factors of responseKeungmo Yang, Pil S Sung, Young K You, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 11, 2017
<sup>18</sup>F-fluorodeoxyglucose uptake of hepatocellular carcinoma as a prognostic predictor in patients with sorafenib treatmentPil Soo Sung, Hye Lim Park, Keungmo Yang, et al.
Journal of Liver Cancer|December 4, 2025
PNPLA3 I148M is unrelated to HCC occurrence but associates with poorer tumor differentiation in Korean MASLD: a prospective cohort of 562 patientsJaejun Lee, Dong Yeop Lee, Jung Hoon Cha, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Liver Cancer|May 7, 2026
Low Tumor Burden Predicts Benefit from Transarterial Treatment in Hepatocellular Carcinoma with Extrahepatic Metastasis: A Nationwide Cohort StudyJaejun Lee, Hyun Yang, Keungmo Yang, et al.
Journal of Korean Medical Science|January 13, 2026
Case 21: A 29-Year-Old Man With Bloating and BorborygmusYoon Kang, Yongeun Cho, Ji Eun Baek, et al.
Translational Gastroenterology and Hepatology|November 11, 2025
The prognostic impact of statin exposure in metabolic dysfunction-associated steatotic liver disease: a cohort studyKeungmo Yang, Seung Yun Chae, Jaejun Lee, et al.
Clinical and Molecular Hepatology|March 10, 2017
Hepatogastric fistula as a rare complication of pyogenic liver abscessKyu Won Lee, Hee Yeon Kim, Chang Wook Kim, et al.
Nature Biomedical Engineering|October 31, 2023
A temperature-responsive intravenous needle that irreversibly softens on insertionKaren-Christian Agno, Keungmo Yang, Sang-Hyuk Byun, et al.
Anticancer Research|July 3, 2019
Reduction of Intrahepatic Tumour by Hepatic Arterial Infusion Chemotherapy Prolongs Survival in Hepatocellular CarcinomaPil Soo Sung, Keungmo Yang, Si Hyun Bae, et al.
Clinical Nutrition (Edinburgh, Scotland)|February 28, 2025
Glucosamine supplementation attenuates progression of metabolic dysfunction-associated steatotic liver disease and related comorbiditiesTom Ryu, Young Chang, Jeong-Ju Yoo, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|June 8, 2019
Pathologic complete response to chemoembolization improves survival outcomes after curative surgery for hepatocellular carcinoma: predictive factors of responseKeungmo Yang, Pil S Sung, Young K You, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 11, 2017
<sup>18</sup>F-fluorodeoxyglucose uptake of hepatocellular carcinoma as a prognostic predictor in patients with sorafenib treatmentPil Soo Sung, Hye Lim Park, Keungmo Yang, et al.
Journal of Liver Cancer|December 4, 2025
PNPLA3 I148M is unrelated to HCC occurrence but associates with poorer tumor differentiation in Korean MASLD: a prospective cohort of 562 patientsJaejun Lee, Dong Yeop Lee, Jung Hoon Cha, et al.
Pageof 6